Literature DB >> 21646376

Choosing a mouse model: experimental biology in context--the utility and limitations of mouse models of breast cancer.

Alexander D Borowsky1.   

Abstract

Genetically engineered mice are critical experimental models for the study of breast cancer biology. Transgenic mice, employing strong mammary epithelial promoters to drive oncogenes, develop carcinomas with phenotypes corresponding to the molecular pathway activated. Gene-targeted (knockout) mice, in which tumor suppressors are deleted, develop mammary neoplasms with phenotypes primarily including patterns seen in spontaneous mouse mammary tumors, albeit at higher rates. Improved genetic engineering, using inducible gene expression, somatic gene transduction, conditional alleles, and crossbreeding for combined/compound genetic engineering yields precise molecular models with exquisite experimental control and phenotypes with comparative pathologic validity. Mammary gland transplantation technology adds a practical and validated method for assessing biologic behavior of selected mammary tissues. Overall, the many mouse models available are a rich resource for experimental biology with phenocopies of breast cancer subtypes, and a variety of practical advantages. The challenge is matching the model to the experimental question.

Entities:  

Mesh:

Year:  2011        PMID: 21646376      PMCID: PMC3181037          DOI: 10.1101/cshperspect.a009670

Source DB:  PubMed          Journal:  Cold Spring Harb Perspect Biol        ISSN: 1943-0264            Impact factor:   10.005


  76 in total

1.  Tumor-producing capabilities of hyperplastic alveolar nodules in virgin and hormone-stimulated BALB/c f. C3H and C3Hf mice.

Authors:  D Medina; K B DeOme; L Young
Journal:  J Natl Cancer Inst       Date:  1970-01       Impact factor: 13.506

2.  Generation of a functional mammary gland from a single stem cell.

Authors:  Mark Shackleton; François Vaillant; Kaylene J Simpson; John Stingl; Gordon K Smyth; Marie-Liesse Asselin-Labat; Li Wu; Geoffrey J Lindeman; Jane E Visvader
Journal:  Nature       Date:  2006-01-05       Impact factor: 49.962

3.  Transgenic Polyoma middle-T mice model premalignant mammary disease.

Authors:  J E Maglione; D Moghanaki; L J Young; C K Manner; L G Ellies; S O Joseph; B Nicholson; R D Cardiff; C L MacLeod
Journal:  Cancer Res       Date:  2001-11-15       Impact factor: 12.701

4.  Development of spontaneous mammary tumors in BALB/c p53 heterozygous mice. A model for Li-Fraumeni syndrome.

Authors:  C Kuperwasser; G D Hurlbut; F S Kittrell; E S Dickinson; R Laucirica; D Medina; S P Naber; D J Jerry
Journal:  Am J Pathol       Date:  2000-12       Impact factor: 4.307

Review 5.  Validity of mouse mammary tumour models for human breast cancer: comparative pathology.

Authors:  R D Cardiff
Journal:  Microsc Res Tech       Date:  2001-01-15       Impact factor: 2.769

6.  In vivo gene expression profile analysis of human breast cancer progression.

Authors:  D C Sgroi; S Teng; G Robinson; R LeVangie; J R Hudson; A G Elkahloun
Journal:  Cancer Res       Date:  1999-11-15       Impact factor: 12.701

7.  Tamoxifen inhibition of estrogen receptor-alpha-negative mouse mammary tumorigenesis.

Authors:  Daniel Medina; Frances S Kittrell; Jamal Hill; Anne Shepard; Gudmundur Thordarson; Powel Brown
Journal:  Cancer Res       Date:  2005-04-15       Impact factor: 12.701

Review 8.  The mammary pathology of genetically engineered mice: the consensus report and recommendations from the Annapolis meeting.

Authors:  R D Cardiff; M R Anver; B A Gusterson; L Hennighausen; R A Jensen; M J Merino; S Rehm; J Russo; F A Tavassoli; L M Wakefield; J M Ward; J E Green
Journal:  Oncogene       Date:  2000-02-21       Impact factor: 9.867

9.  A mammary-specific model demonstrates the role of the p53 tumor suppressor gene in tumor development.

Authors:  D J Jerry; F S Kittrell; C Kuperwasser; R Laucirica; E S Dickinson; P J Bonilla; J S Butel; D Medina
Journal:  Oncogene       Date:  2000-02-21       Impact factor: 9.867

10.  Mice expressing a mammary gland-specific R270H mutation in the p53 tumor suppressor gene mimic human breast cancer development.

Authors:  Susan W P Wijnhoven; Edwin Zwart; Ewoud N Speksnijder; Rudolf B Beems; Kenneth P Olive; David A Tuveson; Jos Jonkers; Mirjam M Schaap; Jolanda van den Berg; Tyler Jacks; Harry van Steeg; Annemieke de Vries
Journal:  Cancer Res       Date:  2005-09-15       Impact factor: 12.701

View more
  33 in total

1.  Basic fibroblast growth factor in an animal model of spontaneous mammary tumor progression.

Authors:  Steven Kao; Jeffrey Mo; Andrew Baird; Brian P Eliceiri
Journal:  Oncol Rep       Date:  2012-03-07       Impact factor: 3.906

Review 2.  On chromatin remodeling in mammary gland differentiation and breast tumorigenesis.

Authors:  Kornelia Polyak
Journal:  Cold Spring Harb Perspect Biol       Date:  2012-03-01       Impact factor: 10.005

Review 3.  The great escape: How metastases of melanoma, and other carcinomas, avoid elimination.

Authors:  Alan Wells; Amanda Clark; Andrew Bradshaw; Bo Ma; Howard Edington
Journal:  Exp Biol Med (Maywood)       Date:  2019-01-06

4.  A Syngeneic ErbB2 Mammary Cancer Model for Preclinical Immunotherapy Trials.

Authors:  Zsófia Pénzváltó; Jane Qian Chen; Clifford G Tepper; Ryan R Davis; Matthew T Silvestrini; Maxine Umeh-Garcia; Colleen Sweeney; Alexander D Borowsky
Journal:  J Mammary Gland Biol Neoplasia       Date:  2019-02-27       Impact factor: 2.673

Review 5.  Obesity and cancer: mechanistic insights from transdisciplinary studies.

Authors:  Emma H Allott; Stephen D Hursting
Journal:  Endocr Relat Cancer       Date:  2015-09-15       Impact factor: 5.678

Review 6.  Pregnancy-induced changes in breast cancer risk.

Authors:  Irma H Russo; Jose Russo
Journal:  J Mammary Gland Biol Neoplasia       Date:  2011-09       Impact factor: 2.673

7.  Screening and analysis of breast cancer genes regulated by the human mammary microenvironment in a humanized mouse model.

Authors:  Mingjie Zheng; Jue Wang; Lijun Ling; Dandan Xue; Shui Wang; Yi Zhao
Journal:  Oncol Lett       Date:  2016-10-24       Impact factor: 2.967

8.  Patient-derived models of human breast cancer: protocols for in vitro and in vivo applications in tumor biology and translational medicine.

Authors:  Yoko S DeRose; Keith M Gligorich; Guoying Wang; Ann Georgelas; Paulette Bowman; Samir J Courdy; Alana L Welm; Bryan E Welm
Journal:  Curr Protoc Pharmacol       Date:  2013-03

9.  Estradiol, progesterone and prolactin modulate mammary gland morphogenesis in adult female plains vizcacha (Lagostomus maximus).

Authors:  Julia Halperin; Veronica B Dorfman; Nicolas Fraunhoffer; Alfredo D Vitullo
Journal:  J Mol Histol       Date:  2013-03-26       Impact factor: 2.611

10.  Transgenic mammary epithelial osteopontin (spp1) expression induces proliferation and alveologenesis.

Authors:  Neil E Hubbard; Qian J Chen; Laura K Sickafoose; Meghan B Wood; Jeffrey P Gregg; Ninnie M Abrahamsson; Jesse A Engelberg; Judith E Walls; Alexander D Borowsky
Journal:  Genes Cancer       Date:  2013-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.